| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/15/2008 | US20080112888 Igfbp2 biomarker |
| 05/15/2008 | CA2669038A1 Salts of dihydroxyanthraquinone carboxylic acids and their therapeutic use |
| 05/15/2008 | CA2668984A1 Methods and devices for the delivery of peptides into the gastric mucosa |
| 05/15/2008 | CA2668731A1 Kinase inhibitors and methods for using the same |
| 05/15/2008 | CA2668682A1 Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a]pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido[1,2-a]pyrimidin-6-one derivatives |
| 05/15/2008 | CA2668645A1 Method of treating asthma, allergic rhinitis, and skin disorders |
| 05/15/2008 | CA2667655A1 Crystalline anti-htnfalpha antibodies |
| 05/15/2008 | CA2641668A1 Desloratadine crystalline forms mixtures having a low level of residual solvents |
| 05/14/2008 | EP1921133A2 System for processing lipoaspirate cells |
| 05/14/2008 | EP1921088A2 Peptides and related molecules that bind to tall-1 |
| 05/14/2008 | EP1920778A2 A composition, its preparation method and its use |
| 05/14/2008 | EP1920775A1 5'Triphosphate oligonucleotide induces anti-viral response |
| 05/14/2008 | EP1920774A1 Composition containing fucoidan or fucoidan hydrolysate and immunopotentiating material |
| 05/14/2008 | EP1920773A1 Compositions for inhibition of anglogenesis |
| 05/14/2008 | EP1920770A1 Therapeutic agent for inflammatory bowel disease and tnf- alpha production inhibitor |
| 05/14/2008 | EP1919954A2 Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins |
| 05/14/2008 | EP1919906A1 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases |
| 05/14/2008 | EP1919905A2 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-recptor tyrosine kinases |
| 05/14/2008 | EP1919891A1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases |
| 05/14/2008 | EP1919873A1 Fredericamycin derivatives |
| 05/14/2008 | EP1919486A2 Core 2 glcnac-t inhibitors |
| 05/14/2008 | EP1771425B1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 05/14/2008 | EP1687026B1 Method for the treatment of multiple sclerosis by inhibiting il-17 activity |
| 05/14/2008 | EP1421084B1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/14/2008 | EP1242592B1 A molecular switch for regulating mammalian gene expression |
| 05/14/2008 | EP1235934B1 Screening method for candidate drugs |
| 05/14/2008 | EP1220948B1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 05/14/2008 | EP1171159B1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
| 05/14/2008 | EP1017418B1 Vaccine composition for preventing or treating c hepatitis |
| 05/14/2008 | EP1003552B1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 05/14/2008 | EP0840749B1 The h-y antigen |
| 05/14/2008 | EP0811075B1 A method for the isolation and purification of lipid cell-wall components |
| 05/14/2008 | EP0772437B9 Compositions for delivery of genetic material |
| 05/14/2008 | CN101180290A Hydogrenated benzo[c] thiophene derivatives as immunomodulators |
| 05/14/2008 | CN101180050A Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists |
| 05/14/2008 | CN101177691A Compositions and methods for enhancing disease resistance in fish |
| 05/14/2008 | CN101177426A Process for separating extracting spherosinin from gansu whin |
| 05/14/2008 | CN101177422A Process for preparing methylation catechin by tea |
| 05/14/2008 | CN101176740A Method for extracting angelica essential oil |
| 05/14/2008 | CN100387708C Method for high level expression of active lymphotoxin-betareceptor immunoglobulin and purification method therefor |
| 05/14/2008 | CN100387703C Fatly phospho embrella Pa-I.H bacterial strain and method of culturing fatty phospho embrella and medicine made from its active component |
| 05/14/2008 | CN100387621C Production of antihuman antigen receptors and use thereof |
| 05/14/2008 | CN100387618C Acellular pertussis vaccines and method of preparation thereof |
| 05/14/2008 | CN100387616C Method for obtaining antigenic structures enhancing specific cross reactivity |
| 05/14/2008 | CN100387597C Amide substituted imidazopyridines |
| 05/14/2008 | CN100387580C Tricyclic triazolobenzazepine, derivatives, process for producing the same, and antiallergic |
| 05/14/2008 | CN100387576C Substituted phenylalkanoic acid derivatives and use thereof |
| 05/14/2008 | CN100387231C Process for preparing colatemo solid preparation and its solid preparation |
| 05/14/2008 | CN100387226C Cepharanthine oral disintegration tablet and its preparing method |
| 05/13/2008 | US7371895 antiinflammatory agents; autoimmune and cardiovascular disorders; atherosclerosis, rheumatoid arthritis, hyperlipemia; better water solubility increases the bioavailability and pharmacokinetics |
| 05/13/2008 | US7371832 Polynucleotides encoding molecules associated with cell proliferation |
| 05/13/2008 | US7371826 Comprising human immunoglobulin g1 fc region, which mediates antibody-dependent cell-mediated cytotoxicity in presence of effector cells more effectively; binds fc gamma receptor iii with better affinity |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371779 Synergistic compositions of N-acylhomoserine lactones and 4-quinolones |
| 05/13/2008 | US7371777 Such as 2-(3-{[(4-ethoxybenzoyl)amino]methyl}-4-ethoxybenzyl)-tetrahydro-2-furancarboxylic acid; antihyperglycemia and antihyperlipemia action |
| 05/13/2008 | US7371772 Bicyclic compound, production and use thereof |
| 05/13/2008 | US7371765 Quinoline derivatives having VEGF inhibiting activity |
| 05/13/2008 | US7371754 Tyrosine kinase inhibitors |
| 05/13/2008 | US7371747 Cyanoalkylamino derivatives as protease inhibitors |
| 05/13/2008 | US7371574 Antibody antagonists of VE-cadherin without adverse effects on vascular permeability |
| 05/13/2008 | US7371535 Detect binding with cells transfected with DNA |
| 05/13/2008 | US7371394 Antigenic composition of a Pseudomonas aeruginosa protein |
| 05/13/2008 | US7371393 Methods for reducing fecal shedding |
| 05/13/2008 | US7371392 Cd40 ligand adjuvant for respiratory syncytial virus |
| 05/13/2008 | US7371390 Vaccine of a hepatitis B viral (HBV) antigen and a human papillomavirus (HPV) antigen with an adjuvant which is a preferential stimulator of TH1 cell response such as QS21 (a Quillaja saponaria saponin); free of a herpes simplex viral antigen; vaccine for adolescents e.g. against cervical cancer |
| 05/13/2008 | US7371385 Method of treating immune pathologies with low dose estrogen |
| 05/13/2008 | US7371383 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders |
| 05/13/2008 | US7371373 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta; free of human serum albumin; stability |
| 05/13/2008 | US7371371 Interleukin-2 mutants with reduced toxicity |
| 05/13/2008 | US7371370 Using colony stimulating factor comprising amino acid sequence variation as therapeutic tools in treatment and prevention of hematopoietic, neurological or reproduction disorders |
| 05/13/2008 | CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89) |
| 05/13/2008 | CA2310222C New composition of matter |
| 05/13/2008 | CA2139655C Deletion mutants as vaccines for cholera |
| 05/08/2008 | WO2008054892A2 Chitin micro-particles as an adjuvant |
| 05/08/2008 | WO2008054247A1 Method for producing apyrogenic immunomodulator |
| 05/08/2008 | WO2008053982A1 Composition for treating allergy |
| 05/08/2008 | WO2008053892A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
| 05/08/2008 | WO2008053588A1 Cytokine production regulator gene and use thereof |
| 05/08/2008 | WO2008053444A2 Treating a respiratory condition with bifidobacterium |
| 05/08/2008 | WO2008053055A1 Prophylactic tuberculosis vaccine |
| 05/08/2008 | WO2008052964A1 3-aminocarbonyi-substituted fused pyrazolo-derivatives as protein kinase modulators |
| 05/08/2008 | WO2008052468A1 New lactobacillus rhamnosus strain, its pharmaceutical composition and the uses thereof, and the method for preparation |
| 05/08/2008 | WO2008052410A1 A supermolecule composition of water-soluble coenzyme q10 and preparation method thereof |
| 05/08/2008 | WO2008052277A1 Crystalline composition of gm-csf/gm-csfr |
| 05/08/2008 | WO2008009407A3 Sulphonylaminocarbonyl derivatives of bile acid amides for use as immunomodulators |
| 05/08/2008 | WO2007103348A3 Process for preparing water-soluble polyethylene glycol conjugates of macrolide immunosuppressants |
| 05/08/2008 | WO2007060038A3 Preparation, comprising iron(iii) complex compounds and redox-active substances |
| 05/08/2008 | US20080108808 Dipeptidyl peptidase inhibitors |
| 05/08/2008 | US20080108807 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 05/08/2008 | US20080108796 Human IL-1 epsilon DNA and polypeptides |
| 05/08/2008 | US20080108678 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; 4-Methylsulfanyl-N-{2-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-acetylamino]-cyclohexyl}-benzamide |
| 05/08/2008 | US20080108659 Poly(adp-ribose)polymerase inhibitors |
| 05/08/2008 | US20080108648 Novel imidazo[1,5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/08/2008 | US20080108638 antiallergen; not direct way to change nature of immunological response to allergen; G-protein-coupled "chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)" antagonist for prostaglandin PGD2, that mediates PGD2-dependent migration of blood Th2 cells; ; asthma, rhinitis, COPD |
| 05/08/2008 | US20080108636 compounds that form covalent bonds with Bruton's tyrosine kinase (Btk). Also described are irreversible inhibitors of Btk. Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are told |
| 05/08/2008 | US20080108628 Treatment of diseases or disorders mediated by T lymphocytes and/or PKC; may be coadminstered with an immunosuppressant, immunomodulatory, anti-inflammatory, antiproliferative or anti-diabetic drug |
| 05/08/2008 | US20080108565 An immunoglobulin heavy chain variable region, an immunoglobulin light chain variable region, together define a single binding site for binding human HGF; neutralizing the activity of HGF |
| 05/08/2008 | US20080108564 Peptide covalently bound to Polyethylene glycol; agonists of the erythropoietin receptor (EPO-R), having amino acid sequence; defective red blood cell production |
| 05/08/2008 | US20080108545 Peptide nucleic acid linked via a disulfide bond to a triphenylphosphonium group; deliver PNA oligomers across the plasma membrane into cells; HIV infection, hepatitis C infection; melanoma, pancreatic adnocarcinoma, actue myeloid leukemia, myeloma, small cell lung cancer, prostate cancer |
| 05/08/2008 | US20080107752 Detoxified venom and constituent neurotoxins; alpha-bungarotoxin, kappa-bungarotoxin, alpha-cobratoxin, alpha-cobrotoxin, alpha-conotoxins, alpha-dendrotoxin, erabutoxin; protect from viral, bacterial, parasitic infections; administer orally, subcutaneously, intramuscularly, intravenously |